SGEN - Seattle Genetics Inc /wa - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (no Diagnostic Substances) - SGEN (1060736)
Filing Date
  
Trade Date
  
Tickers
Insider Name
Trade Type
Share Price $
Value Traded $
Officer
   CEO
   CFO
Director
10% Owner
Other
SIC Industry
Sort by
Max Results
Exclude derivative-related
clear
500 results for SGEN - Yahoo - Tradingview - Stocktwits - SEC

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2015-12-18
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsM - OptEx$9.47+35,036111,248+46%+$331,6920000
D
2015-12-15
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsM - OptEx$9.23+40,50076,212+113%+$373,8150000
D
2015-12-15
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsS - Sale+OE$39.94-40,50076,212-35%-$1,617,4930000
D
2015-12-03
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,720584,060+1%+$20,944-3+100
D
2015-12-03
SGENSiegall Clay BPres, CEOS - Sale+OE$39.99-3,720584,060-1%-$148,763-3+100
M
2015-11-18
SGENBaker FelixDir, 10%P - Purchase$43.94+329,35837,543,143+1%+$14,471,958-3-500
2015-11-17
SGENSiegall Clay BPres, CEOS - Sale$45.40-87,473584,060-13%-$3,970,9510-200
2015-11-11
SGENCline Darren SSVP, CommercialS - Sale$45.68-5,76937,713-13%-$263,548+2+300
M
2015-11-06
SGENBaker FelixDir, 10%P - Purchase$42.95+934,62437,213,785+3%+$40,143,685-4-1-100
2015-11-06
SGENDobmeier EricCOOS - Sale$42.50-17,45280,888-18%-$741,710+40-60
D
2015-11-04
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,718671,533+1%+$20,932-1-3-110
D
2015-11-04
SGENSiegall Clay BPres, CEOS - Sale+OE$43.14-3,718671,533-1%-$160,395-1-3-110
2015-11-05
SGENGryska David WDirS - Sale$43.57-10,00023,950-29%-$435,737-1-3-110
D
2015-10-28
SGENSiegall Clay BPres, CEOM - OptEx$5.12+32,265671,533+5%+$165,058-2+300
D
2015-10-05
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,718639,268+1%+$20,932-3-5+100
D
2015-10-05
SGENSiegall Clay BPres, CEOS - Sale+OE$41.30-3,718639,268-1%-$153,541-3-5+100
D
2015-09-29
SGENSimpson Todd ECFOM - OptEx$13.51+14,801194,675+8%+$199,991-1+2+90
M
2015-09-11
SGENBaker FelixDir, 10%P - Purchase$42.56+5,159,48436,279,161+17%+$219,604,116-2-8-230
D
2015-09-03
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,718639,268+1%+$20,932+5+16-40
D
2015-09-03
SGENSiegall Clay BPres, CEOS - Sale+OE$40.12-3,718639,268-1%-$149,166+5+16-40
D
2015-08-25
SGENSiegall Clay BPres, CEOA - Grant$0.00+64,000639,268+11%+$0+30+100
D
2015-08-20
SGENSiegall Clay BPres, CEOS - Sale+OE$42.02-31,754639,268-5%-$1,334,440+30+100
D
2015-08-25
SGENDobmeier EricCOOA - Grant$0.00+19,00098,340+24%+$0+30+100
D
2015-08-24
SGENDobmeier EricCOOM - OptEx$20.27+4,93398,340+5%+$99,985+30+100
D
2015-08-20
SGENDobmeier EricCOOS - Sale+OE$42.02-8,54898,340-8%-$359,226+30+100
D
2015-08-25
SGENDrachman Jonathan GCMO, EVP, R, DA - Grant$0.00+20,00082,724+32%+$0+30+100
D
2015-08-20
SGENDrachman Jonathan GCMO, EVP, R, DS - Sale+OE$42.02-4,46282,724-5%-$187,513+30+100
D
2015-08-25
SGENCline Darren SSVP, CommercialA - Grant$0.00+12,00043,482+38%+$0+30+100
D
2015-08-20
SGENCline Darren SSVP, CommercialS - Sale+OE$42.02-2,23143,482-5%-$93,757+30+100
D
2015-08-25
SGENSimpson Todd ECFOA - Grant$0.00+17,000179,874+10%+$0+30+100
D
2015-08-20
SGENSimpson Todd ECFOS - Sale+OE$42.02-5,825179,874-3%-$244,794+30+100
D
2015-08-25
SGENLiu Jean IGC, EVP, Leg AffairsA - Grant$0.00+14,00036,400+63%+$0+30+100
D
2015-08-25
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsA - Grant$0.00+15,00076,212+25%+$0+30+100
D
2015-08-20
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsS - Sale+OE$42.02-5,99776,212-7%-$252,021+30+100
D
2015-08-05
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,718657,022+1%+$20,932+2-1-60
D
2015-08-05
SGENSiegall Clay BPres, CEOS - Sale+OE$46.91-3,718657,022-1%-$174,411+2-1-60
D
2015-07-06
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,718657,022+1%+$20,932+1+7-20
D
2015-07-06
SGENSiegall Clay BPres, CEOS - Sale+OE$46.94-3,718657,022-1%-$174,515+1+7-20
D
2015-06-03
SGENSiegall Clay BPres, CEOM - OptEx$5.63+3,718657,022+1%+$20,932+3+3+4-10
D
2015-06-03
SGENSiegall Clay BPres, CEOS - Sale+OE$45.72-3,718657,022-1%-$169,971+3+3+4-10
M
2015-05-19
SGENBaker FelixDir, 10%P - Purchase$42.49+950,88657,603,404+2%+$40,403,604-1-2+12+3
D
2015-05-15
SGENAkkaraju SrinivasDirA - Grant$0.00+3,70021,105+21%+$0+4+3+17+6
D
2015-05-15
SGENGryska David WDirA - Grant$0.00+3,70033,950+12%+$0+4+3+17+6
D
2015-05-15
SGENLippman Marc EDirA - Grant$0.00+3,700128,650+3%+$0+4+3+17+6
D
2015-05-15
SGENMcLaughlin John PeterDirA - Grant$0.00+3,70035,700+12%+$0+4+3+17+6
D
2015-05-15
SGENOrwin John ADirA - Grant$0.00+3,7008,700+74%+$0+4+3+17+6
D
2015-05-15
SGENSimonian Nancy ADirA - Grant$0.00+3,70010,700+53%+$0+4+3+17+6
D
2015-05-15
SGENWelch Daniel GDirA - Grant$0.00+3,70016,819+28%+$0+4+3+17+6
D
2015-05-15
SGENBaker FelixDir, 10%A - Grant$39.94+7,40026,269,5150%+$295,556+2+6+16+6
D
2015-05-08
SGENSiegall Clay BPres, CEOM - OptEx$5.63+52,052657,022+9%+$293,053-1+3+17+12
D
2015-05-08
SGENSiegall Clay BPres, CEOS - Sale+OE$40.65-52,052657,022-7%-$2,116,080-1+3+17+12
D
2015-05-11
SGENBaker FelixDir, 10%M - OptEx$5.11+20,00026,265,8150%+$102,200+1+2+17+8
2015-05-08
SGENDobmeier EricCOOS - Sale$40.38-17,07482,777-17%-$689,380-3-3+13+6
M
2015-05-05
SGENBaker FelixDir, 10%P - Purchase$35.56+1,032,66455,997,022+2%+$36,723,710+8+6+26+16
D
2015-04-08
SGENGryska David WDirM - OptEx$8.38+5,00030,250+20%+$41,900+2-3+7+4
2015-03-13
SGENCline Darren SSVP, CommercialS - Sale$38.65-7,50033,135-18%-$289,8760-3-6+25
D
2015-03-12
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsM - OptEx$9.23+20,00067,209+42%+$184,600-1-4-6+20
D
2015-03-12
SGENHimes Vaughn BEVP, Proc Svcs, Tech OpsS - Sale+OE$36.65-20,00067,209-23%-$732,992-1-4-6+20
M
2015-03-09
SGENBaker FelixDir, 10%P - Purchase$34.66+285,03629,108,727+1%+$9,878,530+5+7+2+13
M
2015-03-03
SGENBaker FelixDir, 10%P - Purchase$34.84+448,84128,823,691+2%+$15,637,120-1+70+13
M
2015-02-24
SGENBaker FelixDir, 10%P - Purchase$33.92+281,11528,374,850+1%+$9,536,2490-2-1+11
D
2015-01-06
SGENSiegall Clay BPres, CEOM - OptEx$5.92+16,804659,710+3%+$99,480-4-4+4+48
D
2015-01-06
SGENSiegall Clay BPres, CEOS - Sale+OE$31.80-16,804659,710-2%-$534,320-4-4+4+48
M
2014-12-15
SGENBaker FelixDir, 10%P - Purchase$31.86+2,883,37828,093,735+11%+$91,859,162+3-3-1+50
2014-12-09
SGENBaker FelixDir, 10%J - Other Sale$0.00-460,22225,102,846+2%-$0-2-6-7+37
M
2014-12-08
SGENBaker FelixDir, 10%P - Purchase$33.82+1,247,89625,102,846+5%+$42,209,731-2-6-7+37
D
2014-12-01
SGENLiu Jean IEVP, Legal Affairs, GCA - Grant$0.00+22,40022,400New+$0-2-8-12+25
D
2014-11-12
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.M - OptEx$9.23+10,00067,209+17%+$92,300+1+4-10+17
D
2014-11-12
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.S - Sale+OE$37.52-10,00067,209-13%-$375,169+1+4-10+17
M
2014-11-06
SGENBaker FelixDir, 10%P - Purchase$34.56+1,653,92524,317,655+7%+$57,154,1590-3-7+8
D
2014-09-04
SGENSiegall Clay BPres, CEOM - OptEx$5.92+5,600659,710+1%+$33,152+1+1-16-15
D
2014-09-04
SGENSiegall Clay BPres, CEOS - Sale+OE$42.54-5,600659,710-1%-$238,224+1+1-16-15
D
2014-08-27
SGENDobmeier EricCOOM - OptEx$12.00+8,33399,765+9%+$99,996+1-6-12-17
D
2014-08-26
SGENSimpson Todd ECFOA - Grant$0.00+17,000168,699+11%+$0-1-5-6-18
D
2014-08-24
SGENSimpson Todd ECFOS - Sale+OE$43.55-3,696168,699-2%-$160,957-1-5-6-18
D
2014-08-26
SGENSiegall Clay BPres, CEOA - Grant$0.00+60,000659,710+10%+$0-1-5-6-18
D
2014-08-24
SGENSiegall Clay BPres, CEOS - Sale+OE$43.55-25,507659,710-4%-$1,110,804-1-5-6-18
D
2014-08-26
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.A - Grant$0.00+15,00067,209+29%+$0-1-5-6-18
D
2014-08-24
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.S - Sale+OE$43.55-3,31067,209-5%-$144,147-1-5-6-18
D
2014-08-26
SGENDrachman Jonathan GCMO, EVP, R, DA - Grant$0.00+20,00066,481+43%+$0-1-5-6-18
D
2014-08-24
SGENDrachman Jonathan GCMO, EVP, R, DS - Sale+OE$43.55-2,77266,481-4%-$120,718-1-5-6-18
D
2014-08-26
SGENDobmeier EricCOOA - Grant$0.00+18,00091,432+25%+$0-1-5-6-18
D
2014-08-25
SGENDobmeier EricCOOS - Sale+OE$43.55-4,81891,432-5%-$209,819-1-5-6-18
D
2014-08-26
SGENBoerner Christopher S.EVP, CommA - Grant$0.00+16,00072,358+28%+$0-1-5-6-18
D
2014-08-24
SGENBoerner Christopher S.EVP, CommS - Sale+OE$43.55-1,24872,358-2%-$54,349-1-5-6-18
DM
2014-08-11
SGENSiegall Clay BPres, CEOM - OptEx$5.92+11,200625,217+2%+$66,304+2+3-1-25
DM
2014-08-11
SGENSiegall Clay BPres, CEOS - Sale+OE$40.38-11,200625,217-2%-$452,220+2+3-1-25
M
2014-06-12
SGENBaker FelixDir, 10%P - Purchase$39.92+216,5954,455,785+5%+$8,645,726-30-13-20
DM
2014-01-10
SGENSiegall Clay BPres, CEOG - Gift$0.00-330,479625,217-35%-$00+2-8-14
D
2014-06-10
SGENSiegall Clay BPres, CEOM - OptEx$5.92+11,200625,217+2%+$66,3040+2-8-14
D
2014-06-10
SGENSiegall Clay BPres, CEOS - Sale+OE$40.14-11,200625,217-2%-$449,5740+2-8-14
M
2014-06-05
SGENBaker FelixDir, 10%P - Purchase$38.16+546,2524,450,551+14%+$20,845,439+4+5-7-7
M
2014-06-02
SGENBaker FelixDir, 10%P - Purchase$34.86+281,9634,437,342+7%+$9,828,093+3+10+6+3
D
2014-05-16
SGENWelch Daniel GDirA - Grant$0.00+3,50013,119+36%+$0-2+3+23+7
D
2014-05-16
SGENLippman Marc EDirA - Grant$0.00+3,500124,950+3%+$0-2+3+23+7
D
2014-05-16
SGENAkkaraju SrinivasDirA - Grant$0.00+3,50017,405+25%+$0-2+3+23+7
D
2014-05-16
SGENSimonian Nancy ADirA - Grant$0.00+3,5007,000+100%+$0-2+3+23+7
D
2014-05-16
SGENMcLaughlin John PeterDirA - Grant$0.00+3,50032,000+12%+$0-2+3+23+7
D
2014-05-16
SGENGryska David WDirA - Grant$0.00+3,50025,250+16%+$0-2+3+23+7
D
2014-05-16
SGENBaker FelixDir, 10%A - Grant$0.00+10,500544,945+2%+$00-3+15+8
D
2014-05-14
SGENBaker FelixDir, 10%M - OptEx$7.26+30,000544,945+6%+$217,8000-3+15+8
DM
2014-05-15
SGENBaker FelixDir, 10%P - Purchase$34.07+189,611544,945+53%+$6,460,5520-3+15+8
AM
2014-05-07
SGENBaker FelixDir, 10%P - Purchase$33.96+488,3824,398,937+12%+$16,583,3680-3+15+8
D
2014-05-09
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.M - OptEx$9.23+10,00055,519+22%+$92,300+2-5+14+5
D
2014-05-09
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.S - Sale+OE$35.00-10,00055,519-15%-$350,000+2-5+14+5
M
2013-05-07
SGENBaker FelixDir, 10%P - Purchase$33.96+488,3824,398,937+12%+$16,583,368+5-3+13-1
D
2014-04-03
SGENSiegall Clay BPres, CEOM - OptEx$5.92+5,600955,696+1%+$33,152+2-9-15-14
D
2014-04-03
SGENSiegall Clay BPres, CEOS - Sale+OE$43.34-5,600955,696-1%-$242,702+2-9-15-14
2014-03-03
SGENBoerner Christopher S.EVP, CommercialA - Grant$0.00+10,00057,514+21%+$00-3-22-21
D
2014-03-05
SGENSiegall Clay BPres, CEOM - OptEx$5.80+9,318955,696+1%+$54,0840-3-22-21
D
2014-03-05
SGENSiegall Clay BPres, CEOS - Sale+OE$52.89-9,318955,696-1%-$492,7960-3-22-21
D
2014-02-28
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.M - OptEx$9.23+11,30055,519+26%+$104,299+1-3-17-20
D
2014-02-21
SGENBerger Franklin MDirM - OptEx$12.76+7,500204,720+4%+$95,700-1-2-15-20
2014-02-21
SGENBoerner Christopher S.SVP, CommercialS - Sale$54.98-1,45246,075-3%-$79,8250-4-14-21
2014-02-20
SGENDrachman Jonathan GCMO, EVP, R, DS - Sale$53.25-1,24148,670-2%-$66,0830-4-14-21
D
2014-02-19
SGENHimes Vaughn BEVP, Tech, Ops., Proc. Sci.M - OptEx$9.23+3,00044,219+7%+$27,690-1-4-12-23
D
2014-02-19
SGENHimes Vaughn BEVP, Tech, Ops., Proc. Sci.S - Sale+OE$52.01-5,08844,219-10%-$264,627-1-4-12-23
D
2014-02-13
SGENSiegall Clay BPres, CEOM - OptEx$10.33+12,142955,696+1%+$125,427-1+4+3-17
D
2014-02-18
SGENSiegall Clay BPres, CEOS - Sale+OE$51.97-100,000955,696-9%-$5,197,010-1+4+3-17
2014-01-21
SGENDobmeier EricCOOS - Sale$47.92-56,01077,833-42%-$2,683,958-4-3+14-27
2014-01-16
SGENDrachman Jonathan GCMO, EVP, R, DS - Sale$45.75-1,20149,911-2%-$54,9460-6+11-29
D
2014-01-10
SGENOrwin John ADirA - Grant$0.00+5,0005,000New+$00+10+17-20
D
2014-01-02
SGENSiegall Clay BPres, CEOM - OptEx$10.33+1,8581,043,5540%+$19,193+4+8+11-8
D
2014-01-02
SGENSiegall Clay BPres, CEOS - Sale+OE$39.27-1,8581,043,5540%-$72,957+4+8+11-8
M
2013-12-12
SGENBaker FelixDir, 10%P - Purchase$39.66+407,0784,387,129+10%+$16,145,428-40+16-1
D
2013-12-05
SGENSiegall Clay BPres, CEOM - OptEx$5.92+18,9961,043,554+2%+$112,456+1-30-3
M
2013-12-03
SGENBaker FelixDir, 10%P - Purchase$43.19+1,005,9014,377,228+30%+$43,442,7320-11-10-13
D
2013-12-02
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,024,5580%+$20,660+1-9-12-14
D
2013-12-02
SGENSiegall Clay BPres, CEOS - Sale+OE$41.25-2,0001,024,5580%-$82,492+1-9-12-14
2013-10-31
SGENDrachman Jonathan GCMO, EVP, R, DA - Grant$0.00+8,10051,112+19%+$0+1-2-3-17
D
2013-11-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,024,5580%+$20,660-2+4+15-12
D
2013-11-01
SGENSiegall Clay BPres, CEOS - Sale+OE$38.63-2,0001,024,5580%-$77,254-2+4+15-12
D
2013-10-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,024,5580%+$20,6600-11-14-12
D
2013-10-01
SGENSiegall Clay BPres, CEOS - Sale+OE$43.87-2,0001,024,5580%-$87,7320-11-14-12
D
2013-09-10
SGENDobmeier EricCOOM - OptEx$22.24+40,000133,843+43%+$889,599+1-1-14+5
D
2013-09-10
SGENDobmeier EricCOOS - Sale+OE$46.40-42,000133,843-24%-$1,948,960+1-1-14+5
DM
2013-09-03
SGENDobmeier EricCOOM - OptEx$13.67+83,223135,843+158%+$1,137,5850+9+3+17
DM
2013-09-03
SGENDobmeier EricCOOS - Sale+OE$42.64-75,000135,843-36%-$3,197,6640+9+3+17
D
2013-09-03
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,000977,2110%+$20,6600+9+3+17
D
2013-09-03
SGENSiegall Clay BPres, CEOS - Sale+OE$43.90-102,000977,211-9%-$4,477,8020+9+3+17
D
2013-09-03
SGENGryska David WDirM - OptEx$10.08+10,00022,000+83%+$100,8000+9+3+17
D
2013-09-03
SGENGryska David WDirS - Sale+OE$42.48-10,00022,000-31%-$424,8000+9+3+17
DM
2013-08-27
SGENSimpson Todd ECFOM - OptEx$16.96+68,129155,395+78%+$1,155,6030+8+6+25
D
2013-08-27
SGENSimpson Todd ECFOS - Sale+OE$41.45-37,763155,395-20%-$1,565,1860+8+6+25
D
2013-08-28
SGENBerger Franklin MDirM - OptEx$12.76+10,000197,220+5%+$127,6000+8+6+25
D
2013-08-19
SGENSiegall Clay BPres, CEOA - Grant$0.00+55,0001,124,558+5%+$0+2+2+11+33
D
2013-08-19
SGENSiegall Clay BPres, CEOS - Sale+OE$40.91-7,6531,124,558-1%-$313,084+2+2+11+33
D
2013-08-19
SGENSimpson Todd ECFOA - Grant$0.00+14,400125,029+13%+$0+2+2+11+33
D
2013-08-19
SGENSimpson Todd ECFOS - Sale+OE$40.91-3,328125,029-3%-$136,148+2+2+11+33
D
2013-08-19
SGENDobmeier EricCOOA - Grant$0.00+18,000127,620+16%+$0+2+2+11+33
D
2013-08-19
SGENDobmeier EricCOOS - Sale+OE$40.91-3,328127,620-3%-$136,148+2+2+11+33
D
2013-08-19
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.A - Grant$0.00+14,40046,307+45%+$0+2+2+11+33
D
2013-08-19
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.S - Sale+OE$40.91-1,73646,307-4%-$71,020+2+2+11+33
D
2013-08-19
SGENBoerner Christopher S.SVP, CommercialA - Grant$0.00+14,00047,527+42%+$0+2+2+11+33
D
2013-08-19
SGENBoerner Christopher S.SVP, CommercialS - Sale+OE$40.91-22647,5270%-$9,246+2+2+11+33
D
2013-08-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,077,2110%+$20,6600-4-20
D
2013-08-01
SGENSiegall Clay BPres, CEOS - Sale+OE$40.03-2,0001,077,2110%-$80,0630-4-20
DM
2013-07-11
SGENSimpson Todd ECFOM - OptEx$13.09+92,527113,957+432%+$1,211,4760+2+8+8
DM
2013-07-11
SGENSimpson Todd ECFOS - Sale+OE$37.45-92,527113,957-45%-$3,465,4740+2+8+8
D
2013-07-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,077,2110%+$20,6600+8+27+19
D
2013-07-01
SGENSiegall Clay BPres, CEOS - Sale+OE$32.59-2,0001,077,2110%-$65,1860+8+27+19
D
2013-06-14
SGENAkkaraju SrinivasDirM - OptEx$8.38+5,00013,905+56%+$41,900+1-7+21+26
D
2013-06-14
SGENAkkaraju SrinivasDirS - Sale+OE$32.75-5,00013,905-26%-$163,750+1-7+21+26
D
2013-06-13
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.M - OptEx$9.23+10,00033,643+42%+$92,300+1-7+21+26
D
2013-06-13
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.S - Sale+OE$32.11-10,00033,643-23%-$321,100+1-7+21+26
D
2013-06-03
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,077,2110%+$20,660+4-1+7+31
D
2013-06-03
SGENSiegall Clay BPres, CEOS - Sale+OE$33.88-2,0001,077,2110%-$67,762+4-1+7+31
D
2013-05-17
SGENBaker FelixDir, 10%A - Grant$0.00+10,500480,649+2%+$0-2-2-13+15
D
2013-05-17
SGENWelch Daniel GDirA - Grant$0.00+3,5009,619+57%+$0-2-2-13+15
D
2013-05-17
SGENSimonian Nancy ADirA - Grant$0.00+3,5003,500New+$0-2-2-13+15
D
2013-05-17
SGENMcLaughlin John PeterDirA - Grant$0.00+3,50028,500+14%+$0-2-2-13+15
D
2013-05-17
SGENLippman Marc EDirA - Grant$0.00+3,500121,450+3%+$0-2-2-13+15
D
2013-05-17
SGENBerger Franklin MDirA - Grant$0.00+3,500187,220+2%+$0-2-2-13+15
D
2013-05-17
SGENGryska David WDirA - Grant$0.00+3,50022,000+19%+$0-2-2-13+15
D
2013-05-17
SGENAkkaraju SrinivasDirA - Grant$0.00+3,50013,905+34%+$0-2-2-13+15
D
2013-05-10
SGENAkkaraju SrinivasDirM - OptEx$12.76+17,50010,405-247%+$223,300+3-4-14+4
D
2013-05-10
SGENAkkaraju SrinivasDirS - Sale+OE$37.17-17,50010,405-63%-$650,430+3-4-14+4
D
2013-05-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,077,2110%+$20,6600+2-7+6
D
2013-05-01
SGENSiegall Clay BPres, CEOS - Sale+OE$36.58-2,0001,077,2110%-$73,1530+2-7+6
D
2013-04-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,077,2110%+$20,660+1+7+6+32
D
2013-04-01
SGENSiegall Clay BPres, CEOS - Sale+OE$35.53-2,0001,077,2110%-$71,062+1+7+6+32
D
2013-03-15
SGENBoerner Christopher S.SVP, CommercialM - OptEx$15.10+8,50033,753+34%+$128,350+4+10+6+45
D
2013-03-15
SGENBoerner Christopher S.SVP, CommercialS - Sale+OE$33.61-8,50033,753-20%-$285,663+4+10+6+45
D
2013-03-11
SGENDobmeier EricCOOM - OptEx$12.11+50,000112,948+79%+$605,671+2+3+16+47
D
2013-03-11
SGENDobmeier EricCOOS - Sale+OE$31.16-60,000112,948-35%-$1,869,471+2+3+16+47
D
2013-03-07
SGENSimpson Todd ECFOM - OptEx$12.12+20,176113,957+22%+$244,610+1+8+12+43
D
2013-03-07
SGENSimpson Todd ECFOS - Sale+OE$30.75-49,718113,957-30%-$1,528,706+1+8+12+43
DM
2013-03-04
SGENDobmeier EricCOOM - OptEx$12.08+100,000122,948+436%+$1,208,000+1+7+14+45
DM
2013-03-04
SGENDobmeier EricCOOS - Sale+OE$29.68-100,000122,948-45%-$2,968,455+1+7+14+45
D
2013-03-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,077,2110%+$20,6600+5+13+40
DM
2013-03-01
SGENSiegall Clay BPres, CEOS - Sale+OE$28.71-95,7501,077,211-8%-$2,749,0170+5+13+40
D
2013-02-26
SGENGryska David WDirM - OptEx$6.69+10,00018,500+118%+$66,900+1+10+28+47
D
2013-02-25
SGENGryska David WDirS - Sale+OE$27.17-10,00018,500-35%-$271,700+1+10+28+47
D
2013-02-01
SGENSiegall Clay BPres, CEOM - OptEx$10.33+2,0001,170,9610%+$20,660+1-2+3+42
D
2013-02-01
SGENSiegall Clay BPres, CEOS - Sale+OE$29.61-2,0001,170,9610%-$59,216+1-2+3+42
DM
2013-01-25
SGENReynolds Thomas CChief Medical OfficerM - OptEx$13.05+7,29057,601+14%+$95,104-3-1-7+33
DM
2013-01-25
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$30.09-7,29057,601-11%-$219,343-3-1-7+33
D
2013-01-15
SGENReynolds Thomas CChief Medical OfficerM - OptEx$11.62+125,07957,601-185%+$1,452,804+1+5-4+35
D
2013-01-15
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$28.00-125,07957,601-68%-$3,502,526+1+5-4+35
D
2013-01-04
SGENDobmeier EricCOOM - OptEx$11.09+60,000122,846+95%+$665,400+5+8+20+41
D
2013-01-04
SGENDobmeier EricCOOS - Sale+OE$24.95-50,983122,846-29%-$1,272,026+5+8+20+41
DM
2013-01-02
SGENSiegall Clay BPres, CEOM - OptEx$5.00+8,2491,170,961+1%+$41,282+5+8+20+41
DM
2013-01-02
SGENSiegall Clay BPres, CEOS - Sale+OE$24.13-8,2491,170,961-1%-$199,043+5+8+20+41
D
2012-12-17
SGENDobmeier EricCOOM - OptEx$10.92+62,418113,829+121%+$681,5730-3+25+27
D
2012-12-17
SGENDobmeier EricCOOS - Sale+OE$23.70-50,000113,829-31%-$1,184,9550-3+25+27
DM
2012-12-06
SGENReynolds Thomas CChief Medical OfficerM - OptEx$11.20+66,58857,601-741%+$745,561+1-2+12+33
DM
2012-12-06
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$25.77-66,58857,601-54%-$1,715,706+1-2+12+33
D
2012-12-05
SGENLippman Marc EDirM - OptEx$6.83+67,500117,950+134%+$461,325-5-8+6+31
D
2012-12-05
SGENLippman Marc EDirS - Sale+OE$25.54-67,500117,950-36%-$1,723,950-5-8+6+31
DM
2012-12-04
SGENReynolds Thomas CChief Medical OfficerM - OptEx$12.12+40,00057,601+227%+$484,800-1-9+2+30
DM
2012-12-04
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$25.59-40,00057,601-41%-$1,023,500-1-9+2+30
D
2012-12-03
SGENWelch Daniel GDirM - OptEx$8.38+3,1196,119+104%+$26,137-1-6-4+30
D
2012-12-03
SGENSiegall Clay BPres, CEOM - OptEx$3.30+8,2501,170,961+1%+$27,225-1-6-4+30
D
2012-12-03
SGENSiegall Clay BPres, CEOS - Sale+OE$25.19-8,2501,170,961-1%-$207,777-1-6-4+30
DM
2012-11-29
SGENReynolds Thomas CChief Medical OfficerM - OptEx$12.04+40,00057,601+227%+$481,684+2-5-4+28
DM
2012-11-29
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$25.41-40,00057,601-41%-$1,016,585+2-5-4+28
DM
2012-11-21
SGENReynolds Thomas CChief Medical OfficerM - OptEx$13.15+30,00057,601+109%+$394,600-10-10+37
DM
2012-11-21
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$25.34-30,00057,601-34%-$760,100-10-10+37
DM
2012-11-19
SGENReynolds Thomas CChief Medical OfficerM - OptEx$15.32+20,00057,601+53%+$306,314-1-1-6+39
DM
2012-11-19
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$24.95-20,00057,601-26%-$499,002-1-1-6+39
D
2012-11-13
SGENDobmeier EricCOOM - OptEx$10.29+24,811101,411+32%+$255,305+2+70+50
D
2012-11-13
SGENDobmeier EricCOOS - Sale+OE$23.59-27,327101,411-21%-$644,724+2+70+50
D
2012-11-08
SGENSimpson Todd ECFOM - OptEx$5.20+72,737143,499+103%+$378,412+1+5+6+67
D
2012-11-08
SGENDobmeier EricCOOM - OptEx$6.45+34,575103,927+50%+$223,107+1+5+6+67
D
2012-11-01
SGENSiegall Clay BPres, CEOM - OptEx$5.00+8,2501,170,961+1%+$41,285+2-5+7+46
D
2012-11-01
SGENSiegall Clay BPres, CEOS - Sale+OE$25.51-8,2501,170,961-1%-$210,476+2-5+7+46
D
2012-10-15
SGENDobmeier EricCOOM - OptEx$10.29+25,00069,352+56%+$257,250+2-5-10+42
D
2012-10-15
SGENDobmeier EricCOOS - Sale+OE$25.01-25,00069,352-26%-$625,295+2-5-10+42
D
2012-10-01
SGENSiegall Clay BPres, CEOM - OptEx$5.00+8,2501,170,961+1%+$41,2850-6-10+30
D
2012-10-01
SGENSiegall Clay BPres, CEOS - Sale+OE$26.59-8,2501,170,961-1%-$219,3440-6-10+30
D
2012-09-10
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.M - OptEx$9.23+10,00033,643+42%+$92,300-1-1-10+21
D
2012-09-10
SGENHimes Vaughn BEVP, Tech. Ops., Proc. Sci.S - Sale+OE$28.79-10,00033,643-23%-$287,900-1-1-10+21
D
2012-09-06
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+48,54057,601+536%+$399,970-2-4-10+17
D
2012-09-06
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$29.75-48,54057,601-46%-$1,444,065-2-4-10+17
DM
2012-09-05
SGENSimpson Todd ECFOM - OptEx$11.69+95,00070,762-392%+$1,110,073-2-5-8+13
DM
2012-09-05
SGENSimpson Todd ECFOS - Sale+OE$28.50-95,00070,762-57%-$2,707,150-2-5-8+13
D
2012-09-04
SGENSiegall Clay BPres, CEOM - OptEx$5.00+8,2501,170,961+1%+$41,285-3-8-10+8
D
2012-09-04
SGENSiegall Clay BPres, CEOS - Sale+OE$26.54-8,2501,170,961-1%-$218,958-3-8-10+8
DM
2012-08-24
SGENSimpson Todd ECFOM - OptEx$10.52+45,00070,762+175%+$473,551+1+50+6
DM
2012-08-24
SGENSimpson Todd ECFOS - Sale+OE$26.97-45,00070,762-39%-$1,213,650+1+50+6
D
2012-08-23
SGENBerger Franklin MDirM - OptEx$10.14+20,000183,720+12%+$202,800+1+50+6
D
2012-08-20
SGENSimpson Todd ECFOA - Grant$0.00+20,00070,762+39%+$000+4+1
D
2012-08-20
SGENSiegall Clay BPres, CEOA - Grant$0.00+74,2501,170,961+7%+$000+4+1
D
2012-08-20
SGENReynolds Thomas CChief Medical OfficerA - Grant$0.00+26,00057,601+82%+$000+4+1
D
2012-08-20
SGENHimes Vaughn BEVP, Technical OperationsA - Grant$0.00+16,00033,643+91%+$000+4+1
D
2012-08-20
SGENDobmeier EricCOOA - Grant$0.00+26,00069,352+60%+$000+4+1
D
2012-08-20
SGENBoerner Christopher S.SVP, CommercialA - Grant$0.00+12,00033,753+55%+$000+4+1
D
2012-08-16
SGENSimpson Todd ECFOM - OptEx$10.29+40,00050,762+372%+$411,6000+2+4+4
D
2012-08-16
SGENSimpson Todd ECFOS - Sale+OE$25.97-40,00050,762-44%-$1,038,8000+2+4+4
2012-08-13
SGENDobmeier EricCOOS - Sale$24.01-25,00043,352-37%-$600,2900+3+6+7
D
2012-08-10
SGENGryska David WDirM - OptEx$5.00+7,50019,000+65%+$37,500+4+5+10+11
DM
2012-08-01
SGENSiegall Clay BPres, CEOM - OptEx$5.00+8,2501,096,711+1%+$41,2850-3+13+22
DM
2012-08-01
SGENSiegall Clay BPres, CEOS - Sale+OE$26.00-8,2501,096,711-1%-$214,4620-3+13+22
D
2012-07-27
SGENWelch Daniel GDirM - OptEx$19.02+3,0003,000New+$57,060-3-7+2+13
D
2012-03-19
SGENSiegall Clay BPres, CEOG - Gift$0.00-5,0001,096,7110%-$00-2-4+2
D
2012-07-02
SGENSiegall Clay BPres, CEOM - OptEx$5.00+8,2501,096,711+1%+$41,2850-2-4+2
D
2012-07-02
SGENSiegall Clay BPres, CEOS - Sale+OE$25.36-8,2501,096,711-1%-$209,2010-2-4+2
D
2012-06-18
SGENDobmeier EricCOOM - OptEx$10.29+25,00068,073+58%+$257,250-2+2+5-5
D
2012-06-18
SGENDobmeier EricCOOS - Sale+OE$25.36-25,00068,073-27%-$634,000-2+2+5-5
D
2012-06-12
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$10.29+10,00017,643+131%+$102,900+2-20-7
D
2012-06-12
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$24.00-10,00017,643-36%-$240,000+2-20-7
DM
2012-06-12
SGENSimpson Todd ECFOM - OptEx$5.29+95,00050,762-215%+$502,421+2-20-7
DM
2012-06-12
SGENSimpson Todd ECFOS - Sale+OE$24.50-95,00050,762-65%-$2,327,285+2-20-7
D
2012-06-08
SGENSimpson Todd ECFOM - OptEx$5.20+35,00050,762+222%+$182,000-3+9+9+3
D
2012-06-08
SGENSimpson Todd ECFOS - Sale+OE$22.97-35,00050,762-41%-$803,950-3+9+9+3
D
2012-06-07
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$10.29+13,56617,643+333%+$139,594-3+9+9+3
D
2012-06-07
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$22.50-13,56617,643-43%-$305,235-3+9+9+3
2012-06-05
SGENGryska David WDirS - Sale$19.75-8,00011,500-41%-$158,000+2+12+17+18
DM
2012-05-16
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$4.45+65,00017,643-137%+$289,250+7+3+26+24
DM
2012-05-16
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$21.54-65,00017,643-79%-$1,399,776+7+3+26+24
D
2012-05-15
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+94931,073+3%+$7,820-1+2+25+20
D
2012-05-15
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$19.75-94931,073-3%-$18,743-1+2+25+20
D
2012-04-25
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+40,00031,073-448%+$329,600+20+5+29
D
2012-04-25
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$19.75-40,00031,073-56%-$790,000+20+5+29
D
2012-04-25
SGENDobmeier EricCOOM - OptEx$10.24+25,00068,073+58%+$255,957+20+5+29
D
2012-04-25
SGENDobmeier EricCOOS - Sale+OE$19.95-25,00068,073-27%-$498,750+20+5+29
D
2012-04-20
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$5.63+38,28117,643-185%+$215,522+3+2+6+35
D
2012-04-20
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$19.51-38,28117,643-68%-$746,862+3+2+6+35
D
2012-04-17
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$5.83+44,21917,643-166%+$257,653+1+1+4+42
D
2012-04-17
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$18.88-44,21917,643-71%-$834,855+1+1+4+42
D
2012-03-22
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+40,00031,073-448%+$329,600+6+5-1+42
D
2012-03-22
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$19.78-40,00031,073-56%-$791,100+6+5-1+42
D
2012-03-19
SGENLippman Marc EDirM - OptEx$4.97+7,500117,950+7%+$37,275+1+5-2+38
DM
2012-03-16
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+40,00031,073-448%+$329,600+1+5-2+38
DM
2012-03-16
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$19.75-40,00031,073-56%-$790,000+1+5-2+38
D
2012-03-13
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.72+69,62617,643-134%+$468,168+2+2-5+42
D
2012-03-13
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$18.59-69,62617,643-80%-$1,294,173+2+2-5+42
DM
2011-08-19
SGENBoerner Christopher S.SVP, CommercialA - Grant$0.00+19,31921,348+952%+$0-3-1+14+47
A
2012-02-28
SGENDobmeier EricCOOS - Sale$18.53-4,00068,073-6%-$74,114-1-1+12+47
D
2012-02-28
SGENDobmeier EricCOOM - OptEx$10.25+46,00072,073+176%+$471,570-1-5+9+46
D
2012-02-28
SGENDobmeier EricCOOS - Sale+OE$18.52-46,00072,073-39%-$851,938-1-5+9+46
D
2012-01-27
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+40,00030,169-407%+$329,6000+4-3+41
D
2012-01-27
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$19.75-40,00030,169-57%-$790,0000+4-3+41
D
2012-01-03
SGENSiegall Clay BPres, CEOM - OptEx$6.34+15,0001,130,055+1%+$95,1000+6+14+48
D
2012-01-03
SGENSiegall Clay BPres, CEOS - Sale+OE$16.73-15,0001,130,055-1%-$250,9590+6+14+48
D
2011-12-30
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%X - OptEx$6.25355,14315,131,223-2%$2,219,644+6+12+18+56
D
2011-12-30
SGENBaker Bros. Capital (Gp), LLCDir, 10%X - OptEx$6.2568,006539,130-11%$425,038+6+12+18+56
D
2011-12-30
SGENBaker Biotech Capital (Gp), LLCDir, 10%X - OptEx$6.25339,7884,966,001-6%$2,123,675+6+12+18+56
D
2011-12-30
SGENBaker / Tisch Capital (Gp), LLCDir, 10%X - OptEx$6.2549,563450,461-10%$309,769+6+12+18+56
D
2011-12-22
SGENDobmeier EricCOOM - OptEx$4.45+10,00071,843+16%+$44,500-10+10+49
D
2011-12-14
SGENLippman Marc EDirM - OptEx$6.40+6,875110,450+7%+$44,0000+1+9+54
D
2011-12-15
SGENGryska David WDirM - OptEx$5.00+4,50019,500+30%+$22,5000+1+9+54
2011-12-09
SGENGryska David WDirS - Sale$18.09-10,00015,000-40%-$180,917-2-1+4+48
D
2011-12-01
SGENSiegall Clay BPres, CEOM - OptEx$6.34+15,0001,130,055+1%+$95,100+2+100+27
D
2011-12-01
SGENSiegall Clay BPres, CEOS - Sale+OE$15.97-15,0001,130,055-1%-$239,597+2+100+27
D
2011-11-09
SGENDobmeier EricCOOM - OptEx$5.25+2,51661,843+4%+$13,209+2-4+6+20
D
2011-11-01
SGENSiegall Clay BPres, CEOM - OptEx$6.34+15,0001,130,055+1%+$95,100-18-26-24-13
D
2011-11-01
SGENSiegall Clay BPres, CEOS - Sale+OE$21.89-15,0001,130,055-1%-$328,413-18-26-24-13
D
2011-10-27
SGENDobmeier EricCOOM - OptEx$5.87+20,91859,327+54%+$122,72500-27-10
D
2011-10-27
SGENDobmeier EricCOOS - Sale+OE$21.95-20,91859,327-26%-$459,15000-27-10
D
2011-10-20
SGENDobmeier EricCOOM - OptEx$6.74+20,46159,327+53%+$137,9070+5-26-8
D
2011-10-20
SGENDobmeier EricCOOS - Sale+OE$20.58-20,46159,327-26%-$421,0240+5-26-8
D
2011-10-07
SGENSimpson Todd ECFOM - OptEx$5.20+24,35049,242+98%+$126,620-1-3-22-15
D
2011-10-07
SGENSimpson Todd ECFOS - Sale+OE$21.97-24,35049,242-33%-$534,970-1-3-22-15
D
2011-10-04
SGENSiegall Clay BPres, CEOM - OptEx$6.34+15,0001,130,055+1%+$95,100+1-2-16-11
D
2011-10-04
SGENSiegall Clay BPres, CEOS - Sale+OE$20.15-15,0001,130,055-1%-$302,283+1-2-16-11
DM
2011-09-20
SGENSiegall Clay BPres, CEOM - OptEx$6.34+30,0001,130,055+3%+$190,200-3-6+2-2
DM
2011-09-20
SGENSiegall Clay BPres, CEOS - Sale+OE$20.12-30,0001,130,055-3%-$603,718-3-6+2-2
D
2011-09-09
SGENMcLaughlin John PeterDirM - OptEx$9.82+25,00025,000New+$245,5000+7+13+2
2011-09-06
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$17.08+1,773323,148+1%+$30,285-3+4+200
2011-09-06
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$17.08+129,18714,776,080+1%+$2,206,641-3+4+200
D
2011-09-02
SGENSiegall Clay BPres, CEOM - OptEx$3.30+16,2511,130,055+1%+$53,628+1+4+17-1
M
2011-08-23
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$15.38+1,165,43514,646,893+9%+$17,925,663+7+8+25+16
M
2011-08-23
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$15.38+17,926321,375+6%+$275,723+7+8+25+16
DM
2011-08-19
SGENSimpson Todd ECFOA - Grant$0.00+21,22049,242+76%+$0+1+12+26+14
DM
2011-08-19
SGENSiegall Clay BPres, CEOA - Grant$0.00+78,1371,113,804+8%+$0+1+12+26+14
DM
2011-08-19
SGENSeeley Bruce J.EVP, CommericalA - Grant$0.00+16,30918,861+639%+$0+1+12+26+14
DM
2011-08-19
SGENRosenberg MorrisEVP, Process SciencesA - Grant$0.00+17,64317,643New+$0+1+12+26+14
DM
2011-08-19
SGENReynolds Thomas CChief Medical OfficerA - Grant$0.00+27,88630,169>999%+$0+1+12+26+14
DM
2011-08-19
SGENHimes Vaughn BEVP, Technical OperationsA - Grant$0.00+17,64317,643New+$0+1+12+26+14
DM
2011-08-19
SGENDobmeier EricCOOA - Grant$0.00+25,22059,327+74%+$0+1+12+26+14
2011-08-01
SGENReynolds Thomas CChief Medical OfficerS - Sale$17.37-1,5391,488-51%-$26,732-9-20+6+22
D
2011-08-01
SGENDobmeier EricCOOM - OptEx$5.25+25,00033,817+284%+$131,250-9-20+6+22
D
2011-07-18
SGENSimpson Todd ECFOM - OptEx$4.63+18,66328,022+199%+$86,500+1-6-220
2011-06-30
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%J - Other Purchase$0.00+10,76613,481,4580%+$0-1-5-24-21
2011-06-30
SGENBaker Bros. Capital (Gp), LLCDir, 10%J - Other Sale$0.00-10,766471,124-2%-$0-1-5-24-21
D
2011-07-01
SGENSiegall Clay BPres, CEOM - OptEx$6.34+15,0001,035,667+1%+$95,1000-2-25-20
D
2011-07-01
SGENSiegall Clay BPres, CEOS - Sale+OE$20.66-15,0001,035,667-1%-$309,8660-2-25-20
2011-06-22
SGENBerger Franklin MDirP - Purchase$20.04+7,000163,720+4%+$140,274+1+5-10-16
D
2011-06-20
SGENSiegall Clay BPres, CEOM - OptEx$6.34+9,0001,035,667+1%+$57,0600+7-10-18
D
2011-06-20
SGENSiegall Clay BPres, CEOS - Sale+OE$20.01-9,0001,035,667-1%-$180,0710+7-10-18
2011-06-20
SGENDobmeier EricCOOS - Sale$20.00-13,3858,817-60%-$267,7000+7-10-18
D
2011-06-09
SGENSiegall Clay BPres, CEOM - OptEx$6.34+1,0001,035,6670%+$6,3400+3+4-7
D
2011-06-09
SGENSiegall Clay BPres, CEOS - Sale+OE$20.00-1,0001,035,6670%-$20,0000+3+4-7
2011-06-09
SGENDobmeier EricChief Business OfficerS - Sale$20.00-3,60022,202-14%-$72,0000+3+4-7
D
2011-06-07
SGENSimpson Todd ECFOM - OptEx$5.20+10,7509,359-773%+$55,900-2-2+3-14
D
2011-06-07
SGENSimpson Todd ECFOS - Sale+OE$19.96-10,7509,359-53%-$214,570-2-2+3-14
D
2011-06-07
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.34+2,5030-100%+$15,869-2-2+3-14
D
2011-06-07
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$19.67-2,5030-100%-$49,243-2-2+3-14
D
2011-05-27
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.34+17,4970-100%+$110,931+1+3+8-18
D
2011-05-27
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$19.50-17,4970-100%-$341,192+1+3+8-18
DM
2011-05-18
SGENReynolds Thomas CChief Medical OfficerM - OptEx$11.09+19,9983,027-118%+$221,778-1+3+5-18
DM
2011-05-18
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$18.71-19,9983,027-87%-$374,108-1+3+5-18
D
2011-05-18
SGENSiegall Clay BPres, CEOM - OptEx$6.34+5,0001,035,6670%+$31,700-1+3+5-18
D
2011-05-19
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.34+20,0000-100%+$126,800-1+3+5-18
D
2011-05-19
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$18.80-20,0000-100%-$376,000-1+3+5-18
D
2011-05-18
SGENSimpson Todd ECFOM - OptEx$4.95+21,2509,359-179%+$105,110-1+3+5-18
D
2011-05-18
SGENSimpson Todd ECFOS - Sale+OE$18.64-21,2509,359-69%-$396,100-1+3+5-18
D
2011-05-13
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.34+20,0000-100%+$126,8000+6+8-10
D
2011-05-13
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$17.80-20,0000-100%-$356,0000+6+8-10
D
2011-05-13
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+20,0003,027-118%+$164,8000+6+8-10
D
2011-05-13
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$17.80-20,0003,027-87%-$356,0000+6+8-10
D
2011-05-13
SGENDobmeier EricChief Business OfficerM - OptEx$5.89+42,71525,802-253%+$251,3820+6+8-10
D
2011-05-13
SGENDobmeier EricChief Business OfficerS - Sale+OE$18.00-42,71525,802-62%-$768,8700+6+8-10
D
2011-05-09
SGENSimpson Todd ECFOM - OptEx$4.45+20,0009,359-188%+$89,000+2+7+11-2
D
2011-05-09
SGENSimpson Todd ECFOS - Sale+OE$17.74-20,0009,359-68%-$354,800+2+7+11-2
D
2011-05-09
SGENSiegall Clay BPres, CEOM - OptEx$8.43+50,0001,030,667+5%+$421,500+2+7+11-2
D
2011-05-09
SGENSiegall Clay BPres, CEOS - Sale+OE$17.35-50,0001,030,667-5%-$867,705+2+7+11-2
D
2011-04-29
SGENSimpson Todd ECFOM - OptEx$4.45+15,0009,359-266%+$66,750-1+4+14+30
D
2011-04-29
SGENSimpson Todd ECFOS - Sale+OE$16.94-15,0009,359-62%-$254,100-1+4+14+30
D
2011-04-29
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+9,9993,027-143%+$82,392-1+4+14+30
D
2011-04-29
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$16.95-11,9153,027-80%-$201,959-1+4+14+30
D
2011-05-02
SGENSiegall Clay BPres, CEOM - OptEx$8.43+50,0001,030,667+5%+$421,500-1+4+14+30
D
2011-05-02
SGENSiegall Clay BPres, CEOS - Sale+OE$17.43-50,0001,030,667-5%-$871,355-1+4+14+30
DM
2011-04-29
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.72+25,0000-100%+$168,000-1+4+14+30
DM
2011-04-29
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$17.15-25,0000-100%-$428,751-1+4+14+30
D
2011-04-14
SGENSiegall Clay BPres, CEOM - OptEx$8.43+50,0001,030,667+5%+$421,500-3+2+18+34
D
2011-04-14
SGENSiegall Clay BPres, CEOS - Sale+OE$15.27-50,0001,030,667-5%-$763,455-3+2+18+34
D
2011-04-07
SGENSiegall Clay BPres, CEOM - OptEx$8.43+50,0001,030,667+5%+$421,500+1-1+11+37
D
2011-04-07
SGENSiegall Clay BPres, CEOS - Sale+OE$16.06-50,0001,030,667-5%-$802,905+1-1+11+37
D
2011-04-05
SGENDobmeier EricChief Business OfficerM - OptEx$5.49+40,00025,802-282%+$219,484-1-3+12+35
D
2011-04-05
SGENDobmeier EricChief Business OfficerS - Sale+OE$16.00-40,00025,802-61%-$640,000-1-3+12+35
D
2011-01-14
SGENSiegall Clay BPres, CEOG - Gift$0.00-5,8331,030,667-1%-$0+2+3+7+28
D
2011-03-17
SGENSiegall Clay BPres, CEOM - OptEx$8.43+200,0001,030,667+24%+$1,686,000+2+3+7+28
D
2011-03-17
SGENSiegall Clay BPres, CEOS - Sale+OE$14.09-200,0001,030,667-16%-$2,817,280+2+3+7+28
2011-02-02
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$15.50+48,197303,449+19%+$747,054+1-2-5-12
2011-02-02
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$15.50+1,751,80313,470,692+15%+$27,152,947+1-2-5-12
D
2010-12-22
SGENDobmeier EricChief Business OfficerM - OptEx$5.25+4,00024,242+20%+$21,0000-5+3+32
D
2010-12-15
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.72+25,0000-100%+$168,000-20+2+27
D
2010-12-15
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$16.22-25,0000-100%-$405,490-20+2+27
D
2010-12-02
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.72+25,0000-100%+$168,000-4-4-3+22
D
2010-12-02
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$15.81-25,0000-100%-$395,295-4-4-3+22
D
2010-11-12
SGENGryska David WDirM - OptEx$5.00+4,00025,500+19%+$20,000+2+7+17+35
D
2010-11-04
SGENRosenberg MorrisEVP, Process SciencesM - OptEx$6.72+25,0000-100%+$168,0000-4+3+21
D
2010-11-04
SGENRosenberg MorrisEVP, Process SciencesS - Sale+OE$14.70-25,0000-100%-$367,3900-4+3+21
D
2010-10-11
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+25,0005,719-130%+$206,0000+1-17-8
D
2010-10-11
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$16.95-25,0005,719-81%-$423,7500+1-17-8
D
2010-10-01
SGENBerger Franklin MDirM - OptEx$8.38+5,000156,720+3%+$41,900+2+5-2-3
D
2010-09-27
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+25,0005,719-130%+$206,000+3+6+9+1
D
2010-09-27
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$14.95-25,0005,719-81%-$373,750+3+6+9+1
D
2010-08-31
SGENSiegall Clay BPres, CEOM - OptEx$3.00+48,3321,036,500+5%+$144,996+2+5+35+23
D
2010-08-24
SGENBerger Franklin MDirM - OptEx$7.55+13,000151,720+9%+$98,140-3-4+1+24
D
2010-06-21
SGENAkkaraju SrinivasDirJ - Other Sale$0.00-50,00010,405-83%-$0-2-7-3+20
D
2010-06-21
SGENAkkaraju SrinivasDirM - OptEx$7.37+50,00010,405-126%+$368,300-2-7-3+20
M
2010-06-07
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$11.94+599,06911,718,889+5%+$7,151,496+3+11+4+26
M
2010-06-07
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$11.94+16,536255,252+7%+$197,402+3+11+4+26
2010-06-04
SGENLippman Marc EDirP - Purchase$12.49+20,000103,575+24%+$249,840+1+13+3+28
2010-05-25
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$11.95+150238,7160%+$1,793+1-5-3+16
2010-05-25
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$11.95+5,41611,119,8200%+$64,722+1-5-3+16
D
2010-05-14
SGENBerger Franklin MDirM - OptEx$7.03+17,000138,720+14%+$119,510+2-3+4+10
D
2010-05-13
SGENBerger Franklin MDirP - Purchase$13.37+5,000138,720+4%+$66,865+2-3+4+10
2010-05-10
SGENLippman Marc EDirP - Purchase$11.92+11,07583,575+15%+$131,995+100+10
D
2010-05-03
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+23,2034,508-124%+$191,193-4+8+3+17
D
2010-05-03
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$12.95-25,0004,508-85%-$323,750-4+8+3+17
M
2010-05-03
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$12.79+561,70911,114,404+5%+$7,183,344-4+8+3+17
M
2010-05-03
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$12.79+15,506238,566+7%+$198,296-4+8+3+17
M
2009-08-11
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$11.06+51,581223,060+30%+$570,520-60+6+22
2009-08-11
SGENBaker Biotech Capital (Gp), LLCDir, 10%P - Purchase$10.75+273,4044,626,213+6%+$2,939,093-60+6+22
2009-08-11
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$10.75+798481,8900%+$8,579-60+6+22
M
2009-08-11
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$11.06+1,868,68610,552,695+22%+$20,668,921-60+6+22
D
2010-04-20
SGENSiegall Clay BPres, CEOM - OptEx$3.00+10,000988,168+1%+$30,000+1+5+8+52
2010-03-30
SGENBerger Franklin MDirP - Purchase$12.05+11,500116,720+11%+$138,5280-2+6+26
M
2010-03-10
SGENBerger Franklin MDirP - Purchase$11.90+13,000105,220+14%+$154,714+4-1+2+8
D
2010-02-17
SGENGryska David WDirM - OptEx$4.18+4,00021,500+23%+$16,720-1+2+14+16
D
2009-12-29
SGENBerger Franklin MDirM - OptEx$5.11+10,00092,220+12%+$51,100-1+4-1+15
D
2009-12-02
SGENHoth Daniel Floyd JrDirM - OptEx$5.06+10,40510,405New+$52,6490-7+15+26
D
2009-10-29
SGENDobmeier EricChief Business OfficerM - OptEx$5.02+6,98519,609+55%+$35,083+2+6+6+32
D
2009-10-07
SGENBerger Franklin MDirM - OptEx$4.18+5,00082,220+6%+$20,900-3-2-6+17
D
2009-09-08
SGENSiegall Clay BPres, CEOM - OptEx$3.00+10,000978,168+1%+$30,000+3+5-22-11
2009-08-18
SGENAkkaraju SrinivasDirP - Purchase$11.47+4,90510,405+89%+$56,260+1+5+27-12
D
2009-07-30
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+25,0003,713-117%+$206,000-1-2+2-15
D
2009-07-30
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$12.47-25,0003,713-87%-$311,725-1-2+2-15
DM
2009-07-29
SGENDobmeier EricChief Business OfficerM - OptEx$5.12+53,00012,206-130%+$271,552-1-2+2-15
DM
2009-07-29
SGENDobmeier EricChief Business OfficerS - Sale+OE$12.36-60,00012,206-83%-$741,806-1-2+2-15
D
2009-07-29
SGENBerger Franklin MDirM - OptEx$4.18+5,00077,220+7%+$20,900-1-30-15
D
2009-07-28
SGENRosenberg MorrisEVP, DevelopmentM - OptEx$6.72+25,0000-100%+$168,000-1-30-15
D
2009-07-28
SGENRosenberg MorrisEVP, DevelopmentS - Sale+OE$11.81-25,0000-100%-$295,243-1-30-15
D
2009-07-20
SGENGryska David WDirM - OptEx$5.00+4,00017,500+30%+$20,000+7+33+26+12
2009-06-25
SGENAkkaraju SrinivasDirP - Purchase$9.21+5,5005,500New+$50,633+3-5+31+9
2009-05-20
SGENBaker Biotech Capital (Gp), LLCDir, 10%P - Purchase$9.72+378,0534,352,809+10%+$3,674,675+1+4+6+7
2009-05-20
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$9.72+746,5718,684,009+9%+$7,256,670+1+4+6+7
2009-05-20
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$9.72+14,576171,479+9%+$141,679+1+4+6+7
2009-05-20
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$9.72+3,710481,092+1%+$36,061+1+4+6+7
2009-05-20
SGENBaker / Tisch Capital (Gp), LLCDir, 10%P - Purchase$9.72+35,253400,898+10%+$342,659+1+4+6+7
D
2008-12-15
SGENDobmeier EricChief Business OfficerM - OptEx$5.25+5,00019,000+36%+$26,2500-1+7+4
D
2008-09-29
SGENDobmeier EricChief Business OfficerM - OptEx$5.25+5,00014,000+56%+$26,250-5-16-14-12
D
2008-09-26
SGENDobmeier EricChief Business OfficerS - Sale+OE$11.53-24,42714,000-64%-$281,575-5-16-14-12
D
2008-09-22
SGENReynolds Thomas CChief Medical OfficerM - OptEx$8.24+12,3092,626-127%+$101,426+2-9-25-9
D
2008-09-22
SGENReynolds Thomas CChief Medical OfficerS - Sale+OE$12.52-12,3092,626-82%-$154,112+2-9-25-9
AD
2008-09-19
SGENAkkaraju SrinivasDirS - Sale+OE$12.74-87,696603,588-13%-$1,117,247-5-9-25-16
AD
2008-09-18
SGENAkkaraju SrinivasDirS - Sale+OE$12.71-49,378617,871-7%-$627,594-5-9-25-16
D
2008-09-22
SGENAkkaraju SrinivasDirS - Sale+OE$12.79-18,601600,559-3%-$237,907-5-9-25-16
D
2008-09-19
SGENAkkaraju SrinivasDirS - Sale+OE$12.74-37,0112,745,518-1%-$471,520-6-12-28-22
D
2008-09-18
SGENAkkaraju SrinivasDirS - Sale+OE$12.71-20,8392,881,851-1%-$264,864+2-10-31-25
D
2008-09-16
SGENDobmeier EricChief Business OfficerM - OptEx$4.66+30,00033,427+875%+$139,700+2-10-31-25
D
2008-09-16
SGENDobmeier EricChief Business OfficerS - Sale+OE$12.25-30,00033,427-47%-$367,455+2-10-31-25
D
2008-08-04
SGENRosenberg MorrisSVP, DevelopmentM - OptEx$6.72+50,0000-100%+$336,000+2+5-7-12
D
2008-08-04
SGENRosenberg MorrisSVP, DevelopmentS - Sale+OE$11.30-50,0000-100%-$564,975+2+5-7-12
D
2008-08-01
SGENSiegall Clay BPres, CEOM - OptEx$3.00+15,000968,168+2%+$45,000+2+8-1-9
D
2008-07-29
SGENAkkaraju SrinivasDirS - Sale+OE$10.85-95,6882,889,893-3%-$1,038,215+6+11+4-7
D
2008-07-28
SGENAkkaraju SrinivasDirS - Sale+OE$10.36-21,2322,949,682-1%-$219,964-1+7+2-7
DM
2008-07-28
SGENJp Morgan Partners Bhca LP10%S - Sale+OE$10.36-21,5002,289,032-1%-$222,740-1+7+2-7
D
2008-07-28
SGENH&q Holdings, Inc.10%S - Sale+OE$10.36-21,5002,289,032-1%-$222,740-1+7+2-7
D
2008-07-25
SGENH&q Holdings, Inc.10%S - Sale+OE$10.81-150,0002,289,166-6%-$1,621,500+5+10+8+1
D
2008-07-25
SGENJp Morgan Partners Bhca LP10%S - Sale+OE$10.81-150,0002,289,166-6%-$1,621,500+5+10+8+1
D
2008-07-25
SGENAkkaraju SrinivasDirS - Sale+OE$10.81-148,1362,965,412-5%-$1,601,350+5+10+8+1
2008-07-25
SGENSiegall Clay BPres, CEOS - Sale$10.78-100,000953,168-9%-$1,077,790-4+9+2-8
D
2008-05-16
SGENAkkaraju SrinivasDirS - Sale+OE$10.39-42,0593,075,155-1%-$436,993-3-6-7+1
D
2008-05-15
SGENAkkaraju SrinivasDirS - Sale+OE$10.14-98,7583,106,314-3%-$1,001,406-3-6-7+1
D
2008-05-15
SGENJp Morgan Partners Bhca LP10%S - Sale+OE$10.14-100,0002,290,363-4%-$1,014,000-3-6-7+1
D
2008-05-14
SGENH&q Holdings, Inc.10%S - Sale+OE$10.10-122,8932,290,984-5%-$1,241,219-2-6-12-11
D
2008-05-14
SGENJp Morgan Partners Bhca LP10%S - Sale+OE$10.10-122,8932,290,984-5%-$1,241,219-2-6-12-11
D
2008-05-13
SGENH&q Holdings, Inc.10%S - Sale+OE$10.06-51,5362,291,748-2%-$518,452-2-6-12-11
D
2008-05-13
SGENJp Morgan Partners Bhca LP10%S - Sale+OE$10.06-51,5362,291,748-2%-$518,452-2-6-12-11
D
2008-05-14
SGENAkkaraju SrinivasDirS - Sale+OE$10.10-121,3653,179,476-4%-$1,225,787+3-10-12+1
D
2008-05-13
SGENAkkaraju SrinivasDirS - Sale+OE$10.06-50,8963,269,387-2%-$512,014+3-10-12+1
M
2008-03-17
SGENBaker Biotech Capital (Gp), LLCDir, 10%P - Purchase$7.90+41,6663,974,756+1%+$328,963+3+6+21+38
M
2008-03-17
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$7.90+330954,6230%+$2,605+3+6+21+38
M
2008-03-17
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$7.90+3,918156,903+3%+$30,933+3+6+21+38
M
2008-03-17
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$7.90+123,4937,937,438+2%+$975,006+3+6+21+38
M
2008-03-12
SGENBaker Biotech Capital (Gp), LLCDir, 10%P - Purchase$8.04+65,0043,933,090+2%+$522,325-6+19+14+48
M
2008-03-12
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$8.04+464953,7740%+$3,728-6+19+14+48
M
2008-03-12
SGENBaker / Tisch Capital (Gp), LLCDir, 10%P - Purchase$8.04+819365,6450%+$6,581-6+19+14+48
M
2008-03-12
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$8.04+464953,7740%+$3,728-6+19+14+48
M
2008-03-12
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$8.04+173,4077,813,945+2%+$1,393,374-6+19+14+48
M
2008-03-12
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$8.04+5,503152,985+4%+$44,218-6+19+14+48
M
2008-02-07
SGENBaker / Tisch Capital (Gp), LLCDir, 10%P - Purchase$9.03+1,158364,8260%+$10,462+3+8-12+36
M
2008-02-07
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$9.01+415953,0690%+$3,741+3+8-12+36
M
2008-02-07
SGENBaker Biotech Capital (Gp), LLCDir, 10%P - Purchase$9.01+34,6533,868,086+1%+$312,377+3+8-12+36
M
2008-02-07
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$9.01+153,5387,640,538+2%+$1,384,057+3+8-12+36
M
2008-02-07
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$9.01+4,883147,482+3%+$44,017+3+8-12+36
2008-01-22
SGENBerger Franklin MDirP - Purchase$9.12+52872,220+1%+$4,815-5-7-2+13
M
2008-01-18
SGENBaker Bros. Capital (Gp), LLCDir, 10%P - Purchase$8.99+5,166952,087+1%+$46,466+3-3-1+17
M
2008-01-18
SGENBaker / Tisch Capital (Gp), LLCDir, 10%P - Purchase$8.99+43,170363,668+13%+$388,284+3-3-1+17
M
2008-01-18
SGENBaker Biotech Capital (Gp), LLCDir, 10%P - Purchase$8.99+578,9163,833,433+18%+$5,206,046+3-3-1+17
M
2008-01-18
SGENBaker Brothers Life Sciences Capital (Gp), LLCDir, 10%P - Purchase$8.99+2,094,2787,487,000+39%+$18,836,669+3-3-1+17
M
2008-01-18
SGEN14159 Capital (Gp), LLCDir, 10%P - Purchase$8.99+67,001142,599+89%+$602,630+3-3-1+17
D
2008-01-17
SGENGryska David WDirM - OptEx$4.18+6,00013,500+80%+$25,080+1+9+10+8
D
2007-12-20
SGENDobmeier EricChief Business OfficerM - OptEx$5.25+5,00029,427+20%+$26,250+1-4-17-27
D
2007-12-14
SGENLippman Marc EDirM - OptEx$0.10+20,00087,500+30%+$2,000-2+9-7-18
D Derivative transaction exists (usually option exercise)
Open: Yahoo - Finviz - Stockcharts - Google

Return to top
S - SaleSale of securities on an exchange or to another person
S - Sale on exerciseSale of securities on an exchange or to another person (after option exercise)
F - OptEx/tax paymentPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person